Longitudinal decline of pulmonary function in cough variant asthma and atopic cough
M. Fujimura, M. Nishitsuji, Y. Nishizawa, T. Kita (Ishikawa, Kanazawa, Japan)
Source: Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Disease area: Airway diseases
Abstract Cough variant asthma (CVA) and atopic cough (AC) are different clinical manifestations of eosinophilic airway inflammation presenting with isolated chronic non-productive cough. Longitudinal change of pulmonary function in CVA and AC is unknown. Thus, we examined the longitudinal change of FEV1 in patients with CVA and AC. Twenty patients with CVA, 14 patients with AC and 271 asymptomatic healthy subjects were prospectively examined. Thirteen patients with CVA were taking long-term inhaled corticosteroid therapy (ICS) (beclomethasone dipropionate 615 ±] 58 μg/day) and other 7 patients were not. Spirometry was taken at first visit, after cough was almost completely relieved on therapy and at least once every year for 5 or more years afterwards. Slope of longitudinal change in FEV1 was -0.029 ±] 0.007, –0.021 ±] 0.022 and -0.028 ±] 0.002 l/year in CVA patients, AC patients and asymptomatic subjects, respectively, and these values were not significantly different. In patients with CVA, the slope in patients without ICS was –0.032 ±] 0.007 l/year, which was not different from that in patients with ICS (-0.027 ±] 0.010 l/year). The pulmonary function decline is not greater in CVA than AC and normal population, and long-term ICS has no benefit for the decline in CVA.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Fujimura, M. Nishitsuji, Y. Nishizawa, T. Kita (Ishikawa, Kanazawa, Japan). Longitudinal decline of pulmonary function in cough variant asthma and atopic cough. Eur Respir J 2002; 20: Suppl. 38, 429
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Maximal airway response in patients with asthma and cough variant asthma Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007
Predictors for asthma onset from cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002
Airway responsiveness in patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 50s Year: 2002
Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma? Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017 Year: 2017
Importance of atopic cough and cough variant asthma as causes of chronic cough in Hokuriku area of Japan Source: Eur Respir J 2003; 22: Suppl. 45, 373s Year: 2003
Differences and similarities between patients with cough variant asthma and cough predominant asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Snoring is related to recurrent wheezing, rhinitis and dyspnea but not to type-1 allergy or bronchial hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004
Cough variant asthma may be a incipience of bronchial asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Bronchial challenge test in patients with chronic persistent cough and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 475s Year: 2003
Bronchial hyperreactivity in children with cough variant of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002
Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004
Epinastine improves cough in eosinophilic bronchitis (atopic cough) Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001
Localization of hyaluronan in airways of patients with cough variant asthma Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
Role of respiratory infection in exacerbations of atopic asthma Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Bronchial hyperresponsiveness and perception of dyspnea in children with allergic rhinitis and bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 441s Year: 2004
Treatment of bronchial asthma and wheezing disorders: chronic Source: ERS Skills Course 2016 Year: 2016
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017